Trials / Recruiting
RecruitingNCT03092180
Optimizing Treatment on Idiopathic Inflammatory Myopathies
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- University of Sao Paulo · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
As a T2T, our patients with idiopathic inflammatory myopathies will receive pulse therapies with methyprednisolone and/or human intravenous immunoglobulin, or only methyprednisolone at disease onset. This scheme is an internal routine protocol of our Service.
Detailed description
To compare two groups of patients as described in Brief Summary.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intravenous Infusion | Intravenous infusion of follow medicine at disease onset: methyprednisolone and/or human intravenous immunoglobulin |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2024-05-06
- Completion
- 2024-12-04
- First posted
- 2017-03-27
- Last updated
- 2024-12-05
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03092180. Inclusion in this directory is not an endorsement.